JESSE I TREU Insider Trading $TBRA Tobira Therapeutics, Inc.
Get free email notifications about insider trading for JESSE I TREU.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JESSE I TREU. JESSE I TREU is 10% Owner in SENOMYX INC ($SNMX) and 10% Owner in INTRALASE CORP ($ILSE) and 10% Owner in Paratek Pharmaceuticals, Inc. ($PRTK) and 10% Owner in SANTARUS INC ($SNTS) and 10% Owner in NUVASIVE INC ($NUVA) and 10% Owner in ALIMERA SCIENCES INC ($ALIM) and 10% Owner in Ocera Therapeutics, Inc. ($TZYM) and Director in Northstar Neuroscience, Inc. ($NSTR) and 10% Owner in ACHILLION PHARMACEUTICALS INC ($ACHN) and 10% Owner in Achaogen Inc ($AKAO) and Director in Tobira Therapeutics, Inc. ($TBRA) and 10% Owner in CADENCE PHARMACEUTICALS INC ($CADX) and Director in SENORX INC ($SENO) and Director in Pernix Sleep, Inc. ($SOMX) and Director in CoLucid Pharmaceuticals, Inc. ($CLCD) and 10% Owner in INTERCELL USA, INC. ($IOMI) and Director in Aldeyra Therapeutics, Inc. ($ALDX) and 10% Owner in Vanda Pharmaceuticals Inc. ($VNDA) and 10% Owner in Volcano Corp ($VOLC) and 10% Owner in ZOGENIX, INC. ($ZGNX) and Director in VERACYTE, INC. ($VCYT) and 10% Owner in Orexigen Therapeutics, Inc. ($OREX) and 10% Owner in Dicerna Pharmaceuticals Inc ($DRNA) and 10% Owner in Evoke Pharma Inc ($EVOK) and 10% Owner in Esperion Therapeutics, Inc. ($ESPR) and Director in TANDEM DIABETES CARE INC ($TNDM) and 10% Owner in Clovis Oncology, Inc. ($CLVS) and 10% Owner in REVA Medical, Inc. ($RVA) and 10% Owner in Durata Therapeutics, Inc. ($DRTX).
JESSE I TREU in Tobira Therapeutics, Inc.
Trading Symbol: TBRAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JESSE I TREU: Director
Holdings: 14,920 shares
Latest Transaction: Jan 05 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JESSE I TREU in Tobira Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKAO, ACHN, ALDX, ALIM, CADX, CLVS, CLCD, DRNA, DRTX, ESPR, EVOK, IOMI, ILSE, NSTR, NUVA, TZYM, OREX, PRTK, SOMX, RVA, SNTS, SNMX, SENO, TNDM, TBRA, VNDA, VCYT, VOLC, ZGNX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 05 2015 | TBRA | Tobira Therapeutic ... | TREU JESSE I | Director | Option Exercise | A | 0.91 | 159,261 | 144,928 | 159,261 | |
Jan 03 2014 | TBRA | Tobira Therapeutic ... | TREU JESSE I | Director | Option Exercise | A | 4.77 | 9,640 | 45,983 | 9,640 | |
Aug 28 2013 | TBRA | Tobira Therapeutic ... | TREU JESSE I | Director | Option Exercise | A | 4.00 | 17,964 | 71,856 | 17,964 | |
Aug 28 2013 | TBRA | Tobira Therapeutic ... | TREU JESSE I | Director | Option Exercise | C | 0.00 | 7,407 | 0 | 0 | |
Aug 28 2013 | TBRA | Tobira Therapeutic ... | TREU JESSE I | Director | Option Exercise | C | 0.00 | 2,899 | 0 | 0 | |
Aug 28 2013 | TBRA | Tobira Therapeutic ... | TREU JESSE I | Director | Option Exercise | C | 0.00 | 4,233 | 0 | 0 | |
Aug 28 2013 | TBRA | Tobira Therapeutic ... | TREU JESSE I | Director | Option Exercise | C | 0.00 | 225,913 | 0 | 0 | |
Aug 28 2013 | TBRA | Tobira Therapeutic ... | TREU JESSE I | Director | Option Exercise | C | 0.00 | 894,120 | 0 | 0 | |
Aug 28 2013 | TBRA | Tobira Therapeutic ... | TREU JESSE I | Director | Option Exercise | C | 0.00 | 270,568 | 0 | 0 | |
Aug 28 2013 | TBRA | Tobira Therapeutic ... | TREU JESSE I | Director | Option Exercise | C | 0.00 | 394,969 | 0 | 0 | |
Aug 28 2013 | TBRA | Tobira Therapeutic ... | TREU JESSE I | Director | Buy | C | 0.00 | 7,407 | 0 | 14,920 | 7.5 K to 14.9 K (+98.59 %) |
Aug 28 2013 | TBRA | Tobira Therapeutic ... | TREU JESSE I | Director | Buy | C | 0.00 | 2,899 | 0 | 7,513 | 4.6 K to 7.5 K (+62.83 %) |
Aug 28 2013 | TBRA | Tobira Therapeutic ... | TREU JESSE I | Director | Buy | C | 0.00 | 4,233 | 0 | 4,614 | 381 to 4.6 K (+1,111.02 %) |
Aug 28 2013 | TBRA | Tobira Therapeutic ... | TREU JESSE I | Director | Buy | P | 4.00 | 750,000 | 3,000,000 | 2,571,117 | 1.8 M to 2.6 M (+41.18 %) |
Aug 28 2013 | TBRA | Tobira Therapeutic ... | TREU JESSE I | Director | Buy | C | 0.00 | 225,913 | 0 | 1,821,117 | 1.6 M to 1.8 M (+14.16 %) |
Aug 28 2013 | TBRA | Tobira Therapeutic ... | TREU JESSE I | Director | Buy | C | 0.00 | 894,120 | 0 | 1,595,204 | 701.1 K to 1.6 M (+127.53 %) |
Aug 28 2013 | TBRA | Tobira Therapeutic ... | TREU JESSE I | Director | Buy | C | 0.00 | 270,568 | 0 | 701,084 | 430.5 K to 701.1 K (+62.85 %) |
Aug 28 2013 | TBRA | Tobira Therapeutic ... | TREU JESSE I | Director | Buy | C | 0.00 | 394,969 | 0 | 430,516 | 35.5 K to 430.5 K (+1,111.12 %) |
Page: 1